Publications of Tiago Fleming Outeiro
All genres
Journal Article (100)
41.
Journal Article
87, pp. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 42.
Journal Article
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
43.
Journal Article
404, pp. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 44.
Journal Article
116 (51), pp. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 45.
Journal Article
28, pp. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 46.
Journal Article
47, pp. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 47.
Journal Article
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 48.
Journal Article
47 (3), pp. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 49.
Journal Article
85 (5), pp. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 50.
Journal Article
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 51.
Journal Article
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology 52.
Journal Article
47, pp. 197 - 207 (2019)
The role of LRRK2 in cell signalling. Biochemical Society Transactions 53.
Journal Article
33 (2), pp. 2116 - 2131 (2019)
Monitoring α-synuclein multimerization in vivo. The FASEB Journal 54.
Journal Article
14, 5 (2019)
Dementia with Lewy bodies: an update and outlook. Molecular neurodegeneration 55.
Journal Article
27 (1), pp. 79 - 91 (2019)
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorganic & Medicinal Chemistry 56.
Journal Article
28 (1), pp. 31 - 50 (2019)
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Human Molecular Genetics 57.
Journal Article
18 (8), foy108 (2018)
Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. FEMS Yeast Research 58.
Journal Article
33 (11), pp. 1675 - 1684 (2018)
Sensing α-Synuclein from the outside via the prion problem: implications for neurodegeneration. Movement Disorders 59.
Journal Article
55, pp. 8754 - 8763 (2018)
Diabetes mellitus as a risk factor for Parkinson's disease: a molecular point of view. Molecular Neurobiology 60.
Journal Article
38, pp. 1539 - 1550 (2018)
Secretion and uptake of α-synuclein via extracellular vesicles in cultured cells. Cellular and Molecular Neurobiology